Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1975 3
1976 2
1977 3
1978 1
1982 4
1983 3
1984 2
1985 4
1988 4
1989 9
1990 7
1991 4
1992 2
1993 2
1994 4
1998 1
1999 1
2001 2
2002 3
2003 1
2004 3
2006 1
2008 1
2011 1
2017 1
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
A phase 3 trial of bevacizumab in ovarian cancer.
Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM; ICON7 Investigators. Perren TJ, et al. N Engl J Med. 2011 Dec 29;365(26):2484-96. doi: 10.1056/NEJMoa1103799. N Engl J Med. 2011. PMID: 22204725 Free article. Clinical Trial.
[Breast cancer: breast saving therapy].
Tulusan AH, Bühner M, Büttner A, di Paolo M, Lang N, Sauer R. Tulusan AH, et al. Ther Umsch. 1993 May;50(5):334-8. Ther Umsch. 1993. PMID: 8378889 Review. German.
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.
Kaufmann M, von Minckwitz G, Smith R, Valero V, Gianni L, Eiermann W, Howell A, Costa SD, Beuzeboc P, Untch M, Blohmer JU, Sinn HP, Sittek R, Souchon R, Tulusan AH, Volm T, Senn HJ. Kaufmann M, et al. Among authors: tulusan ah. J Clin Oncol. 2003 Jul 1;21(13):2600-8. doi: 10.1200/JCO.2003.01.136. J Clin Oncol. 2003. PMID: 12829681 Review.
[Preoperative chemotherapy in primary operable breast cancer with a dose-dense combination of doxorubicin and docetaxel (ADoc) - Experience of the GEPARDO-GABG study group].
von Minckwitz G, Raab G, Schütte M, Hilfrich J, Blohmer JU, Gerber B, Costa SD, Merkle E, Eidtmann H, Lampe D, Jackisch C, du Bois A, Tulusan AH, Gademann G, Sinn HP, Caputo A, Graf E, Kaufmann M. von Minckwitz G, et al. Among authors: tulusan ah. Zentralbl Gynakol. 2001 Sep;123(9):497-504. doi: 10.1055/s-2001-18222. Zentralbl Gynakol. 2001. PMID: 11709742 Review. German.
[DCIS and HER2/neu].
Tulusan AH. Tulusan AH. Onkologie. 2002 Dec;25 Suppl 5:11-2; discussion 13. Onkologie. 2002. PMID: 23573612 German. No abstract available.
[Antiemetic therapy in cisplatin chemotherapy].
Grünsteidel W, Schmidt C, Tulusan AH, Merkle E. Grünsteidel W, et al. Among authors: tulusan ah. Gynakol Rundsch. 1989;29 Suppl 2:374-7. Gynakol Rundsch. 1989. PMID: 2613053 German. No abstract available.
72 results